Optimize Financial Inc raised its stake in shares of Crocs, Inc. (NASDAQ:CROX - Free Report) by 73.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 7,128 shares of the textile maker's stock after purchasing an additional 3,020 shares during the quarter. Optimize Financial Inc's holdings in Crocs were worth $757,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Costello Asset Management INC bought a new position in shares of Crocs during the 1st quarter worth about $32,000. Larson Financial Group LLC lifted its position in Crocs by 541.8% in the first quarter. Larson Financial Group LLC now owns 353 shares of the textile maker's stock worth $37,000 after purchasing an additional 298 shares during the period. IMA Advisory Services Inc. bought a new position in Crocs in the first quarter worth $40,000. Brooklyn Investment Group bought a new position in Crocs in the first quarter worth $40,000. Finally, Salem Investment Counselors Inc. bought a new position in Crocs in the first quarter worth $53,000. Institutional investors own 93.44% of the company's stock.
Insider Buying and Selling at Crocs
In other Crocs news, EVP Susan L. Healy acquired 2,000 shares of Crocs stock in a transaction on Tuesday, August 12th. The shares were bought at an average price of $76.56 per share, with a total value of $153,120.00. Following the completion of the purchase, the executive vice president owned 50,078 shares in the company, valued at $3,833,971.68. This trade represents a 4.16% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director John B. Replogle bought 3,261 shares of the stock in a transaction dated Friday, August 8th. The stock was acquired at an average price of $76.69 per share, with a total value of $250,086.09. Following the completion of the purchase, the director owned 15,417 shares of the company's stock, valued at $1,182,329.73. This represents a 26.83% increase in their position. The disclosure for this purchase can be found here. Insiders own 3.00% of the company's stock.
Crocs Price Performance
NASDAQ:CROX traded down $3.52 during trading hours on Friday, reaching $77.43. The company had a trading volume of 2,712,591 shares, compared to its average volume of 1,794,906. The stock has a 50-day moving average of $93.64 and a two-hundred day moving average of $99.35. Crocs, Inc. has a one year low of $73.76 and a one year high of $151.13. The firm has a market capitalization of $4.23 billion, a PE ratio of 20.76, a PEG ratio of 1.87 and a beta of 1.40. The company has a quick ratio of 0.97, a current ratio of 1.54 and a debt-to-equity ratio of 0.97.
Crocs (NASDAQ:CROX - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The textile maker reported $4.23 earnings per share for the quarter, beating analysts' consensus estimates of $4.01 by $0.22. Crocs had a return on equity of 44.15% and a net margin of 5.72%.The firm had revenue of $1.15 billion for the quarter, compared to analysts' expectations of $1.15 billion. During the same period in the prior year, the business posted $4.01 earnings per share. The business's revenue was up 3.4% compared to the same quarter last year. Crocs has set its Q3 2025 guidance at EPS. Analysts forecast that Crocs, Inc. will post 13.2 earnings per share for the current year.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the company. Bank of America reduced their target price on Crocs from $135.00 to $99.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Needham & Company LLC raised their target price on Crocs from $89.00 to $100.00 and gave the stock a "buy" rating in a research report on Friday, August 29th. Barclays reaffirmed an "equal weight" rating and issued a $81.00 target price (down from $119.00) on shares of Crocs in a research report on Friday, August 8th. Monness Crespi & Hardt reduced their target price on Crocs from $140.00 to $92.00 and set a "buy" rating for the company in a research report on Friday, August 8th. Finally, UBS Group dropped their target price on Crocs from $110.00 to $85.00 and set a "neutral" rating for the company in a report on Monday, August 11th. Eight analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $105.33.
Read Our Latest Analysis on Crocs
Crocs Profile
(
Free Report)
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
See Also

Before you consider Crocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.
While Crocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.